Bliss GVS Pharma lost 6.04% to Rs 96.45 at 12:31 IST on BSE after net profit fell 27.6% to Rs 4.68 crore on 10.4% decline in net sales to Rs 60.92 crore in Q4 March 2016 over Q4 March 2015.
The result was announced after market hours yesterday, 24 May 2016.Meanwhile, the S&P BSE Sensex was up 436.39 points or 1.72% at 25,741.86.
On BSE, so far 1.04 lakh shares were traded in the counter as against average daily volume of 77,121 shares in the past one quarter. The stock hit a low of Rs 90 so far during the day, which is a 52-week low for the counter. The stock hit a high of Rs 103.25 so far during the day. The stock had hit a record high of Rs 210.90 on 7 October 2015. The stock had underperformed the market over the past one month till 24 May 2016, sliding 14.71% compared with Sensex's 2.06% fall. The scrip had also underperformed the market in past one quarter, declining 33.5% as against Sensex's 9.6% rise.
The small-cap company has equity capital of Rs 10.31 crore. Face value per share is Rs 1.
Bliss GVS Pharma is a fast-growing pharmaceutical company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.
Powered by Capital Market - Live News
